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We present further evidence in support of the notion that 
Borrelia burgdoiferi is possibly involved in the pathogenesis of 
morphea and lichen sclerosus et atrophicus (LSA). Running a 
nested polymerase chain reaction (PCR) with a primer set 
specific for the flagellin gene of B. burgdoiferi enabled us to 
demonstrate the presence of Borrelia DNA in skin biopsies of 
patients with morphea (nine of nine) or LSA (six of six). 
lliopsy specimens obtained from patients with erythema 
chronicum migrans (two patients, four of four samples) and 
acrodermatitis chronica atrophicans (one patient, one of one 
sample) also show~d positive P~R results: By contrast., th~re 
was no amplification of BorrellO DNA 111 control bIOpSies 
M orphea and lichen sclerosus et atrophicus (LSA) are connective tissue disorders that share histo-pathologic features, such as cellular inflammatory processes at beginning stages and sclerosis or atro-phy of collagen and elastic fibers at later stages. 
Recently, a spirochetal origin has been postulated for morphea and 
[,SA on the basis of histologic, immunohistochemical, and serologic 
findings [1 -4]; however, conflicting reports exist about a positive 
Borrelia bu rgdorferi serology in patients with morphea and LSA [5-
1]. Furthermore, because the. de~onstration and classification ~f 
spirochetes in tissue sections IS dIfficult, the IdentIficatIOn of artI-
flc ts cannot be completely excluded. Although some investigators 
successfully isolated spirochetes from morphea lesions [4,8]' this 
procedure is laborious and of low yield, espe.c~ally at later ~tages of 
Lyme borreliosis. Therefore, a lughly sensItive and speCIfic new 
method such as the polymerase chain reaction (PCR) provides a 
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Abbrevia tions: 
ACA: acrodermatitis chronica atrophicans 
ECM: erythema chronicum migrans 
EDT A: ethylenediametriaacetic acid 
ELISA: enzyme-linked immunosorbent assay 
LSA: lichen sclerosus et atrophicus 
PCR: polymerase chain reaction 
TE: Tris-HCI + EDTA 
Taq: thermophilus aquaticus 
either from patients with chronic eczema (three of three) or 
psoriasis (two of two) or from normal skin (three of three). 
~ntibodies directed against B. burgdoiferi were only detected 
111 the serum of patients with erythema chronicum migrans 
(two of two) and acrodermatitis chronica atrophicans (one of 
one) but were not present in cases of morphea (five of five), 
LSA (three of three), or in control subjects (three of three). 
These data suggest that B. burgdoiferi may playa role in the 
pathogenesis of both morphea and LSA. Furthermore, we 
conclude that PCR analysis provides an important diagnostic 
tool, even in seronegative Borrelia infections.] Inllest Dermatol 
100:717-720,1993 
valuable tool in the detection of even small numbers of spirochetes 
persisting in the skin [9] . 
. In the present study, we investigated skin biopsy samples of pa-
tIents :WIth eIther morphea or LSA by PCR analysis with Borrelia 
flagellll1- gene-specific primers . American and European Borrelia 
strains, as well as biopsies from patients with confirmed erythema 
chronicum migrans (ECM) or acrodermatitis chronica atrophicans 
(ACA) , were used as positive controls. Inflammatory dermatoses 
and normal skin samples served as negative controls. 
MATERIALS AND METHODS 
Patients Tissue for PCR analysis originated either from the ar-
chIval paraffin-embedded material of the Dermatopathological Lab-
oratory ?r from paraffin-embedded biopsies prepared for routine 
dIagnostIcs that had been obtained after informed consent from 
patients attending the Department of Dermatology, University 
Medical Center Steglitz, Berlin. The following diagnoses were es-
tablished on the basis of both clinical and histopathologic evalua-
t~on: ACA (one patient), ECM (two patients), morphea (nine pa-
tIents), LSA (SIX patients), psoriasis (two patients), and chronIC 
eczema (three patients) (Table I) . Three patients with morphea, one 
wIth LSA, and one with ECM remembered a tick bite at the SIte of 
the lesion (Table I). Normal skin was obtained from two healthy 
subjects with negative Borrelia serology and from one patient with 
morphea (patient 14). In one patient with ECM (patient 3), three 
biopsies were taken from the edge and center of the lesion and from 
perilesional skin. The clinical il1anifestations of morphea were of 
the non-disseminated plaque type and in one case (patient 18) of the 
atrophodermia Pasini - Pierini type. All but one of the patients wIth 
LSA had genital LSA. In one case, the localization ofLSA was on the 
left shoulder (patient 4). Patients with morphea or LSA were se-
lected for PCR analysis if there was histologic evidence of an acute 
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Table I. Characterization of Specimens Examined by PCR 
ELISAJ 
Patient Age Localization and 
Number ' Genderb (year) Diagnosis' Lesion Type Duration IgM IgG PCR 
1 F 25 ACA Left elbow 10 years + + + 
2 F 66 ECM Right thigh 3 weeks + + 
3a M 41 ECM' Right thigh, center of lesion 3 months + + + 
+ + 3b Right thigh, edge of lesion + 
+ + 3c Right thigh, perilesional skin + 
+ 4 F 71 LSA Left shoulder 2 years NO NO 
5 F 49 LSA Vulvar 4 years + 
6 F 51 LSA Vulvar 20 years + 
7 F 27 LSA' Vulvar 18 months + 
8 M 41 LSA Preputial 5 years NO NO + 
9 F 69 LSA Vulvar 1 year NO NO + 
10 F 28 HEA Neck 
11 F 82 PSO Back 16 years 
12 M 58 PSO Abdomen 2 years NO NO 
13 F 68 MOR' Abdomen, neck; multiple plaques 6 months + 
+ 14a F 16 MOF.<. Abdomen, single plaque 10 years 
14b Abdomen, healthy skin 
+ 15 M 20 MOR' Lumbar, single plaque, Wac ring 10 years 
+ 16 F 32 MOR Back, single plaque, lilac ring 4 months NO ND 
+ 17 F 57 MOR Trunk; multiple plaques; lilac ring 8 months NO NO 
+ 18 F 47 MOR Disseminated, Pasini - Pierini 2 months NO NO 
19 F 57 MOR Right hip, single plaque 10 years NO NO + 
+ 20 F 29 MOR Abdomen, multiple plaques, lilac ring 20 years 
+ 21 M 14 MOR Abdomen, single plaque 1 year 
22 F 60 HEA Back 
23 M 14 ECZ Abdomen 18 months NO NO 
24 M 62 ECZ Genera lized 2 months NO NO 
25 M 25 ECZ Legs, forearm 6 months NO NO 
• Letters indicate different biopsy specimens obtained from the same patient. 
! F, female; M, male. 
, ECM, ery thema chronicum migrans; ACA, acrodermatitis chronica atrophicans; HEA, healthy skin; LSA, lichen sc1erosus et atrophicus; MOR, morphea; PSO, psoriasis 
vulgaris; ECe., chronic eczema. 
J Flagellin ELISA (Dako, Denmark); NO, not done. 
, Skin lesion(s) developed at the site of a tick bite. 
or subacute inflammatory process. None of the patients had been 
specifically treated with antibiotics, such as penicillins, cephalospo-
rins, or tetracyclines, for suspected spirochetal infection before skin 
biopsies were taken. 
Serologic Tests Serum samples (Table I) were tested for anti-
borrelial antibodies by a flagellin enzyme-linked immunosorbent 
assay (ELISA) [10]. Results were confirmed by Western blot analysis 
as previously described [11] . 
peR DNA was extracted from paraffin-embedded tissue samples 
according to Rogers et al [12]. Briefly, tissue sections were deparaf-
finized with xylene and ethanol; 15 mg of dried tissue was sus-
pended in 1 ml TE9 buffer {0.5 M Tris {hydroxymethylamino-
methane (Tris - HCI, pH 9.0; 0.02 M ethylenediaminetriacetic 
acid (EDTA); 0.01 M NaCI) and digested with 500 ,ug/ml protein-
ase K (Merck, Darmstadt, Germany) at 55°C overnight. The DNA 
was then extracted by use of phenolch loroform and ether [1 3]. After 
subsequent ethanol precipitation, the DNA pellet was dissolved in 
40,111 TEbuffer{10 mM Tris-HCI,pH 7.6; 2 mMEDTA). 5,ugof 
DNA suspension was used in a nested PCR, with two primer pairs 
derived from the flagellin gene of B. burgdorferi. Amplification was 
performed in a DNA Thermal Cycler (Poly C hain II; Polygen, Lan-
gen, Germany). A reaction mixture of 50,111 contained: 50 mmol/I 
KCI; 10 mmol/I Tris-HCI, pH 8.3; 1.5 mmol/I MgCI2 ; 0.01% 
gelatin; 200 mmol/I of each deoxynucleotide triphosphate 
(Boehringer Mannheim, Mannheim, Germany). After add ition of 
1 U Taq (Thermophil us aquatic us) polymerase (Amersham, Ger-
many), the mixture was covered w ith 100,111 mineral oil (Sigma 
Chemical Co., St. Louis, MO). External primers were 5'-CTGCT-
GGCATGGGAGTTTCT-3' and 5-TCAATTGCATACTCAG-
TACT-3' [14] . PCR conditions were as follows: denaturation at 
94 ° C for 30 sec, annealing at 48 ° C for 1 min, and extension at 
72 °C for 2 m in. After 40 cycles, a 5-,111 volume of the fi.rst PCR 
reaction mixture was used for amplification with the internal 
primers 5'-AAGGAATTGGCAGTTCAATC-3' and 5'-ACAG-
CAATAGCTTCATCTTG-3' [15]. Thirty amplification cycles 
were performed under the conditions described above. Identifi.ca-
tion ofpCR products was done by agarose gel electrophoresis . Posi-
tive samples gave rise to a 290-bp flagellin subfragment (Fig 1). In a 
previous experiment, we demonstrated the specificity of the result-
ing product by restriction enzyme analysis [15]. Furthermore, we 
showed that the primers used in this PCR assay do not hybridize 
with the flagell in gene of other bacteria, such as Treponema pallidwll, 
Treponema denticola, Yersillia enterocolitica, and Escherichia co li. As posi-
tive controls, the B. b~lrgdorferi strains RTI (tick isolate; R. Lange, 
Berlin, Germany) [11] and B31 (ATCC 35210) were used. To avoid 
false-positive PCR results, the usual precautions [16] were taken 
and in addition to the above-mentioned samples, at least two nega-
tive controls (distilled water) were processed in each experiment. In 
one single experiment, 10 encoded samples (including water con-
trols) were subjected to DNA extraction. DNA amplification was 
performed at least two times on each DNA sample. 
RESULTS 
A specific amplification product of 290 bp was detected in the pa-
tients with morphea (nine of nine) and LSA (six of six), as well as in 
those withECM (two of two) and ACA (one of one) (Fig 1; Table I). 
In contrast, no specific amplification was seen in the control samples 
(samples 10- 12, 14b, and 22 - 25) processed in the same experi-
ment (Fig 1; Table I) . Biopsy specimens taken from the edge and 
center of ECM lesions and from perilesional skin (patient 3) were 
PCR positive. Borrelia DNA was also detected in lesional skin from 
the patient with atrophoderma of Pasini-Pierini (patient 18). Of 
note, LSA was PCR positive not only in the patients with vulvar or 
preputial LSA, but also in patient 4 with the extragenital manifesta-
tion. Serologic tests revealed anti-borrelial antibodies only in the 
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fi ure L Agarose gel electrophoresis of Borrelia DNA in skin samples ~ controls. (Ialle 1) ACA; (Iau es 2 aud 3a-3c) ECM; (Ialles 4-9) LSA; ~~nes 13 - 21) morphea; (Iau c 14b) normal skin from patient 14; (Idlles 11 
\' d 12) psoriasis; (Iall es 23-25) ECM; (Inu es 10 MId 22) nom1al skin; (-) 
::lstilled water; (+*) B. bllrgdotjeri strains RT1;. (+ •• ) B. burgd01"eri strain B31; (M) molecular weight marker (MW V; Boehnnger, Mannhelm, Germany); 
(bp) base paIr. 
c'ent s with ECM (two of two) and ACA (one of one). All investi-P:t~d patients with morphea (five patients). LSA (three patients). 
gnd psoriasis (one patl ent), as well as the two healthy control sub-3 . jeets were seronegative. 
DISCUSSION 
Immunologic factors [17 - 19) as well as a genetic predisposition 
120,21] and hormonal factors [22J have been discussed as being 
involved in the pathogenesIs of morphea and LSA. An altered rate of 
collagen synthesis has been reported 111 morphe:1 [23]. The ll1vol~e­
ment of intercellular matrIX molecules 111 elastIc tlssue destructlon 
in LSA has also been discussed [24]. Although the coexistence of 
JIlorphea and LSA is often reported [25,26)' It IS stili debatable 
hether they are both involved in a related pathologic process [27]. 
;ecent investigations have revealed Borrelia organisms in lesional 
skin from patients with morphea and LSA and thu.s support a possi-
ble etiologic relationship between these two sklll dIsorders [1,2,4.8]. 
In one case of seronegative morphea. we were able to demonstrate 
Borrelia antigen by immunohistochemistry and PCR analysis, as 
well as active infection by a T -cell assay [3]. To confirm our data 
from this c ase in a larger patient group, we performed a nested PCR 
using f1agellin gene - specific primers. 
Because we used nested oligonucleotide primers and have investi-
gated their specificity [15]. false-positive re s~tlts with these primers 
~e very unlikely. In the present study, we did not amplify all sam-
ples with an internal positive control. s uch as prin:ers . for cellu lar 
DNA. (This is commonly practiced III the quantltatlOn of Viral 
genome to show that the samples can be amplifi ed w.ith another set 
of primers .) Therefore. our negative results theoretically could be 
false-negatives because they could be not ampldiable; however, tillS 
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is unlikely because there was DNA in all lanes (Fig 1), and the DNA 
resulting from phenol chloroform and ether extraction is very pure. 
PCR revea led Borrelia DNA in all patients with morphea (9/9) and 
LSA (6/6) investigated. PCR was also positive in specimens from 
seronegative patients (Table I). These findings are in accordance 
with previous studies that have shown the lack of antispiroche tal 
antibodies in certain forl11s of syphilis [28] and chronic Lyme borre-
liosis [29) . Therefore, the presence of B. bllrgdorJeri infection cannot 
be excluded by the absence of anti-borrelial serum antibodies. 
In summary. we have shown that B. bllrgdorJeri can be present 
even in the skin of seronegative patients with morphea and LSA. 
Thus, persistent spirochetes may contribute to the pathogenesis of 
morphea and LSA. The skin lesions of three patients with morphea 
and one with LSA developed at the site of a preceding tick bite 
(Table I). Because the time from the causative tick bite to the devel-
opment of the scl erotic lesions may be several years apart, it is not 
surprising th at the connection with a tick bite is rarely made by the 
patients. Also, it is possible that the location of the chronic lesions is 
distinct from the primary inoculation site: after hematoge nous 
spread. the spirochetes m ay persist at sites of predilection with a 
lower blood supply and a lower temperature, such as the acral sites 
of th e extremities (A CA), the pinna, the nipples (borreliallym.pho-
cytoma), or the outer genitalia (LSA); however, it remains unclear 
whether intact B. burgdorferi orga nisms or pe rsisting Borrelia compo-
nents in the tissue are the causative agent of Illorphea and LSA or 
whether Immunologic features of the infected patients play the 
predominant role in the pathogenesis of these diseases. 
W e conclude that patients with a cI inical diagnosis of morph ea 
and LSA should be further investigated for B. bllrgdoiferi by sensitive 
methods such as PCR, especially in seronegative cases. In th e 
present study, a small group of selected patients w ith morphea and 
LSA with acute or subacute inflammatory skin lesions were exam-
ined. Therefore, investigation of randomly selected larger groups is 
necessary to provide statistical significa nce for the correlation of 
Borrelia infection and morphea and LSA. Further studies are re-
quired to determine whether th e progression of morphea and LSA 
leSIOns can be halted by adequate antibiotic treatment in patients 
with confirmed Borrelia infection. 
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